FCMT
AST

Founders Capital Management (Texas)’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Founders Capital Management (Texas)’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7,000
Closed -$4K – 355
2018
Q4 		$4K Buy
7,000
+4,000
+133% +$4.15K ﹤0.01% 308
2018
Q3 		$4K Hold
3,000
– – ﹤0.01% 292
2018
Q2 		$4K Hold
3,000
– – ﹤0.01% 300
2018
Q1 		$4K Buy
3,000
+1,000
+50% +$2.09K ﹤0.01% 341
2017
Q4 		$5K Buy
+2,000
New +$5.06K ﹤0.01% 327

Founders Capital Management (Texas)'s AST Position: Q1 2019 in Review

Founders Capital Management (Texas) sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 7,000 shares — an estimated $4K sold.

Founders Capital Management (Texas) first reported a position in AST in Q4 2017 and held it in 5 quarters. The position peaked at $5K in Q4 2017. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

  • Founders Capital Management (Texas) reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
  • Founders Capital Management (Texas) sold 7,000 Asterias Biotherapeutics Inc. Series A shares in Q1 2019, an estimated $4K.
  • Founders Capital Management (Texas) first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2017 and held it in 5 quarters.
  • Founders Capital Management (Texas)'s Asterias Biotherapeutics Inc. Series A position peaked at $5K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on Founders Capital Management (Texas)'s 13F filing for Q1 2019, filed 17 Apr 2019.